Pyc Therapeutics Limited

PYC.ASX

Health Care

Biotechnology research and development Peptide drug discovery

Market Data

Price

$1.350

-0.0%

Market Cap

$1.3B

P/E Ratio

-100000.0x

EPS

$-0.084

Div. Yield

0.00%

52-Week Change

+0.0%

Recent Announcements

18 May 2026 Sph Neutral

Ceasing to be a substantial holder

Firetrail Investments Pty Ltd ceased to be a substantial holder.

13 Feb 2026 Sph Neutral

Becoming a substantial holder

RA Capital Healthcare Fund GP, LLC and related entities have become substantial holders in PYC Therapeutics Limited, acquiring 83,850,000 ordinary shares (8.89% voting power) for $125,775,000 in cash on February 11, 2026.

Get real-time alerts for PYC

Receive AI-powered earnings summaries and instant notifications when Pyc Therapeutics Limited releases results.